Cas:1242339-65-6 5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid manufacturer & supplier

Chemical Name:5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid

CAS.NO:1242339-65-6

Synonyms:5-(1,3-Benzodioxol-5-yl)-2-pyridinecarboxylic acid;2-Pyridinecarboxylic acid, 5-(1,3-benzodioxol-5-yl)-

Molecular Formula:C₁₃H₉NO₄

Molecular Weight:243.215

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:464.0±45.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.642

PSA:68.65000

Exact Mass:243.053162

LogP:1.80

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-(1,3-Benzodioxol-5-yl)-2-pyridinecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridinecarboxylic acid, 5-(1,3-benzodioxol-5-yl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(1,3-Benzodioxol-5-yl)-2-pyridinecarboxylic acid Use and application,5-(1,3-Benzodioxol-5-yl)-2-pyridinecarboxylic acid technical grade,usp/ep/jp grade.

Related News: Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid manufacturer We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid supplier In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid vendor In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 5-(Benzo[d][1,3]dioxol-5-yl)picolinic acid factory In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks.